Display Settings:

Format

Send to:

Choose Destination
    Curr Clin Pharmacol. 2009 Jan;4(1):53-61.

    Recent advances in obesity pharmacotherapy.

    Source

    Faculty of Pharmacy and Biochemistry, University of Buenos Aires, Junín, 956, (C1113AAD) Buenos Aires, Argentina. marcos.mayer@gmail.com

    Abstract

    Obesity is considered a worldwide epidemic. Weight reduction by means of lifestyle changes is difficult to achieve, and pharmacotherapy is frequently needed. Although all currently approved anti-obesity agents have proven to be effective to achieve some degree of weight reduction and improve cardiometabolic risk factors, different compounds differ in their mechanism of action and safety profile. However, it is still difficult to achieve and maintain therapeutic objectives along time. The aim of the present article is to summarize the main characteristics of available anti-obesity agents and to explore novel agents that may provide significant clinical benefits in the future.

    PMID:
    19149502
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk